PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.
作者信息
Lowenberg Daniella, Thorn Caroline F, Desta Zeruesenay, Flockhart David A, Altman Russ B, Klein Teri E
机构信息
Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartments of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.
出版信息
Pharmacogenet Genomics. 2014 Feb;24(2):133-8. doi: 10.1097/FPC.0000000000000019.
Abstract
摘要
相似文献
1
PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.药物基因组知识库总结：异环磷酰胺的作用途径、药代动力学和药效学。
Pharmacogenet Genomics. 2014 Feb;24(2):133-8. doi: 10.1097/FPC.0000000000000019.
2
An overview of cyclophosphamide and ifosfamide pharmacology.环磷酰胺与异环磷酰胺药理学概述。
Pharmacotherapy. 1997 Sep-Oct;17(5 Pt 2):146S-154S.
3
Pharmacology of ifosfamide.
Oncology. 2003;65 Suppl 2:2-6. doi: 10.1159/000073350.
4
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.异环磷酰胺及其代谢产物的临床药代动力学和药效学
Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004.
5
Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6.CYP3A4和CYP2B6对异环磷酰胺代谢的立体选择性。
Xenobiotica. 2006 May;36(5):367-85. doi: 10.1080/00498250600598486.
6
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer.异环磷酰胺的药代动力学和代谢与通过彗星试验评估的癌症患儿DNA损伤的关系。
Br J Cancer. 2005 May 9;92(9):1626-35. doi: 10.1038/sj.bjc.6602554.
7
Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.人细胞色素P450及其常见多态性对异环磷酰胺和氘代异环磷酰胺的羟基化和N-脱氯乙基化作用
Drug Metab Dispos. 2015 Jul;43(7):1084-90. doi: 10.1124/dmd.115.063628. Epub 2015 May 1.
8
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.对肉瘤患者通过红霉素呼气试验测定的异环磷酰胺药代动力学、毒性及其与CYP3A4活性的关系进行评估。
Cancer. 2007 Jun 1;109(11):2315-22. doi: 10.1002/cncr.22669.
9
New insights into the pharmacokinetics and metabolism of (R,S)-ifosfamide in cancer patients using a population pharmacokinetic-metabolism model.
Pharm Res. 2000 Jun;17(6):645-52. doi: 10.1023/a:1007561727948.
10
Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.酮康唑和利福平对细胞色素P450介导的异环磷酰胺代谢的调节作用。
Clin Pharmacol Ther. 2001 Aug;70(2):132-41. doi: 10.1067/mcp.2001.117283.
引用本文的文献
1
Historical Perspective and Current Trends in Anticancer Drug Development.抗癌药物研发的历史回顾与当前趋势
Cancers (Basel). 2024 May 15;16(10):1878. doi: 10.3390/cancers16101878.
2
Morin provides therapeutic effect by attenuating oxidative stress, inflammation, endoplasmic reticulum stress, autophagy, apoptosis, and oxidative DNA damage in testicular toxicity caused by ifosfamide in rats.桑色素通过减轻异环磷酰胺所致大鼠睾丸毒性中的氧化应激、炎症、内质网应激、自噬、细胞凋亡及氧化性DNA损伤发挥治疗作用。
Iran J Basic Med Sci. 2023;26(10):1227-1236. doi: 10.22038/IJBMS.2023.71702.15580.
3
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy.新辅助化疗治疗高危软组织肉瘤的药物遗传学分析
J Pers Med. 2022 Apr 11;12(4):618. doi: 10.3390/jpm12040618.
4
Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney.异环磷酰胺毒性诱导肝和肾常见上游调节剂的研究。
Int J Mol Sci. 2021 Nov 11;22(22):12201. doi: 10.3390/ijms222212201.
5
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.基于候选基因法的欧洲女性儿童癌症幸存者队列中CYP450基因变异对性腺损伤的影响：泛癌生命研究结果
Cancers (Basel). 2021 Sep 13;13(18):4598. doi: 10.3390/cancers13184598.
6
Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.广泛的长非编码基因失调与脂肪酸代谢、细胞分裂和免疫反应基因网络有关，发生在接触外源化学物的大鼠肝脏中。
Toxicol Sci. 2020 Apr 1;174(2):291-310. doi: 10.1093/toxsci/kfaa001.
7
Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin.给予柚汁或柚皮苷的小鼠体内异环磷酰胺的药代动力学参数。
Sci Rep. 2019 Nov 12;9(1):16621. doi: 10.1038/s41598-019-53204-3.
本文引用的文献
1
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.细胞色素 P450 酶在药物代谢中的作用：基因表达调控、酶活性及遗传变异的影响。
Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16.
2
Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.丙烯醛和氯乙醛：细胞和无细胞毒性生物标志物的研究。
Chem Biol Interact. 2013 Feb 25;202(1-3):259-66. doi: 10.1016/j.cbi.2012.11.017. Epub 2012 Dec 7.
3
Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.左旋肉碱下调异环磷酰胺诱导的范可尼综合征大鼠模型氧化应激和硝化应激凋亡信号通路。
Oxid Med Cell Longev. 2012;2012:696704. doi: 10.1155/2012/696704. Epub 2012 Nov 13.
4
Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.TP53 和 MDM2 基因型与肉瘤治疗反应的相关性。
Cancer. 2013 Mar 1;119(5):1013-22. doi: 10.1002/cncr.27837. Epub 2012 Nov 16.
5
Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochips.微流控生物芯片培养的 MDCK 细胞中海柔比星作用的转录组学分析。
Genomics. 2012 Jul;100(1):27-34. doi: 10.1016/j.ygeno.2012.05.001. Epub 2012 May 10.
6
Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.复发性上皮性卵巢癌患者因异环磷酰胺引起的致命代谢性脑病：两例报告。
Cancer Res Treat. 2011 Dec;43(4):260-3. doi: 10.4143/crt.2011.43.4.260. Epub 2011 Dec 27.
7
Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report.异环磷酰胺治疗肉瘤时的急性肝毒性：一例报告
J Med Case Rep. 2011 May 13;5:180. doi: 10.1186/1752-1947-5-180.
8
The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes.组成型雄烷受体在人肝细胞中氧化磷酰胺介导的药物代谢酶诱导中的作用。
Pharm Res. 2011 Aug;28(8):2034-44. doi: 10.1007/s11095-011-0429-2. Epub 2011 Apr 13.
9
Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.肉碱缺乏和氧化应激在异环磷酰胺诱导的范科尼综合征大鼠模型中引发心脏毒性。
Oxid Med Cell Longev. 2010 Jul-Aug;3(4):266-74. doi: 10.4161/oxim.3.4.12859.
10
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.基于 UPLC-ESI-QTOFMS 的代谢组学研究在小鼠体内环磷酰胺和异环磷酰胺的比较代谢。
Biochem Pharmacol. 2010 Oct 1;80(7):1063-74. doi: 10.1016/j.bcp.2010.06.002. Epub 2010 Jun 10.
Zotero 插件